Wang, R.* ; Gomez Salazar, M.* ; Pruñonosa Cervera, I.* ; Coutts, A.* ; French, K.* ; Pinto, M.M.* ; Gohlke, S.* ; Garcia-Martin, R.* ; Blüher, M. ; Schofield, C.J.* ; Kourtzelis, I.* ; Stimson, R.H.* ; Bénézech, C.* ; Christian, M.* ; Schulz, T.J.* ; Gudmundsson, E.F.* ; Jennings, L.L.* ; Gudnason, V.G.* ; Chavakis, T. ; Morton, N.M.* ; Emilsson, V.* ; Michailidou, Z.*
Adipocyte deletion of the oxygen-sensor PHD2 sustains elevated energy expenditure at thermoneutrality.
Nat. Commun. 15:7483 (2024)
Enhancing thermogenic brown adipose tissue (BAT) function is a promising therapeutic strategy for metabolic disease. However, predominantly thermoneutral modern human living conditions deactivate BAT. We demonstrate that selective adipocyte deficiency of the oxygen-sensor HIF-prolyl hydroxylase (PHD2) gene overcomes BAT dormancy at thermoneutrality. Adipocyte-PHD2-deficient mice maintain higher energy expenditure having greater BAT thermogenic capacity. In human and murine adipocytes, a PHD inhibitor increases Ucp1 levels. In murine brown adipocytes, antagonising the major PHD2 target, hypoxia-inducible factor-(HIF)-2a abolishes Ucp1 that cannot be rescued by PHD inhibition. Mechanistically, PHD2 deficiency leads to HIF2 stabilisation and binding of HIF2 to the Ucp1 promoter, thus enhancing its expression in brown adipocytes. Serum proteomics analysis of 5457 participants in the deeply phenotyped Age, Gene and Environment Study reveal that serum PHD2 associates with increased risk of metabolic disease. Here we show that adipose-PHD2-inhibition is a therapeutic strategy for metabolic disease and identify serum PHD2 as a disease biomarker.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Brown Adipose-tissue; Optimal Housing Temperatures; Thermal Environment; Kidney-disease; Hif-alpha; Hypoxia; Thermogenesis; Glucose; Obesity; Protects
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 15,
Heft: 1,
Seiten: ,
Artikelnummer: 7483
Supplement: ,
Reihe
Verlag
Nature Publishing Group
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
Institute of Pancreatic Islet Research (IPI)
POF Topic(s)
30201 - Metabolic Health
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-506501-001
G-502600-008
Förderungen
NHS Research Scotland (NRS), through the Edinburgh Clinical Research Facility
Chief Scientist Office
Rosetrees Trust
Wellcome Trust - Academy of Medical Sciences
Wellcome Trust ISSF3
British Heart Foundation/University of Edinburgh Centre of Research Excellence Award
Copyright
Erfassungsdatum
2024-10-09